SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes
DOI: https://doi.org/10.2147/PPA.S397424
2023-02-19
Patient Preference and Adherence
Abstract:Joshua Wells, 1 Chao Wang, 2 Kevin Dolgin, 3 Reem Kayyali 1 1 Department of Pharmacy, Kingston University, Kingston upon Thames, KT1 2EE, UK; 2 Faculty of Health, Science, Social Care and Education, Kingston University, Kingston upon Thames, KT2 7LB, UK; 3 Behavioural Science Department, Observia, Paris, 75015, France Correspondence: Reem Kayyali, Department of Pharmacy, Kingston University, Penrhyn Road, Kingston upon Thames, KT1 2EE, UK, Tel/Fax +44 208 417 2561, Email Purpose: Poor medication adherence (MA) is linked to an increased likelihood of hospital admission. Early interventions to address MA may reduce this risk and associated health-care costs. This study aimed to evaluate a holistic Patient Reported Outcome Measure (PROM) of MA, known as SPUR, as a predictor of general admission and early readmission in patients living with Type 2 Diabetes. Patients and Methods: An observational study design was used to assess data collected over a 12-month period including 6-month retrospective and 6-month prospective monitoring of the number of admissions and early readmissions (admissions occurring within 30 days of discharge) across the cohort. Patients (n = 200) were recruited from a large South London NHS Trust. Covariates of interest included: age, ethnicity, gender, level of education, income, the number of medicines and medical conditions, and a Covid-19 diagnosis. A Poisson or negative binomial model was employed for count outcomes, with the exponentiated coefficient indicating incident ratios (IR) [95% CI]. For binary outcomes (Coefficient, [95% CI]), a logistic regression model was developed. Results: Higher SPUR scores (increased adherence) were significantly associated with a lower number of admissions (IR = 0.98, [0.96, 1.00]). The number of medical conditions (IR = 1.07, [1.01, 1.13]), age ≥ 80 years (IR = 5.18, [1.01, 26.55]), a positive Covid-19 diagnosis during follow-up (IR = 1.83, [1.11, 3.02]) and GCSE education (IR = 2.11, [1.15,3.87]) were factors associated with a greater risk of admission. When modelled as a binary variable, only the SPUR score (− 0.051, [− 0.094, − 0.007]) was significantly predictive of an early readmission, with patients reporting higher SPUR scores being less likely to experience an early readmission. Conclusion: Higher levels of MA, as determined by SPUR, were significantly associated with a lower risk of general admissions and early readmissions among patients living with Type 2 Diabetes. Keywords: predictive model, logistic regression, patient reported outcome measure, type 2 diabetes In 1997, a systematic review of interventions to support patients with prescribed medicines was conducted by Haynes et al. 1 The review concluded that the potential benefits of such interventions, which were often complex and difficult to deliver, were limited by the current level of medication adherence achieved by patients. The World Health Organisation (WHO) later quoted Haynes et al in 2001 2 with a call to action for a systems approach to improving the management of chronic conditions, stating that increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments. Despite this call to action, over two decades later conservative estimates suggest that the cost of non-adherence to health-care systems sits somewhere between €1.25Bn to $290Bn per year across parts of Europe and the US. 2,3 The staggering costs associated with non-adherence are somewhat less surprising when we begin to quantify the extent of the issue. Although adherence rates are highly dependent on factors such as the clinical condition, type and/or complexity of drug therapy, many studies cite within the range of approximately only 30–75% of patients taking their medications as prescribed. 4–11 Poor adherence is associated with worsening clinical outcomes in the hospital setting, which include an increased risk of admission, 12 mortality, 13 and length of stay. 14 These cases are often preventable 12 and present significant economic implications, particularly in the event of early readmissions (admissions occurring within 30 days of discharge) whereby financial penalties have been brought against hospitals in the UK since 2011 for these events. 15 Conversely, interventions specifically designed to support patients with their medicines have shown encouraging improvements in mortality, readmission risk and primary medication adherence in areas such as cardiovascular disease, 16 mental health, 17 general medicine, 18 and post-surgical care. -Abstract Truncated-
medicine, general & internal